QUICK MARKET SUMMARY: CONSUMER: 🔸 Colgate ( $CL): New $5B buyback, dividend to $0.52. 🔸 $NCLH: Upgraded to Equal Weight (Morgan Stanley). 🔸 Lennar ( $LEN): Q1 EPS $2.14 (est. $1.73), rev $7.63B (est. $7.49B); Q2 orders 22.5k-23.5k, deliveries 19.5k-20.5k. 🔸 Nike ( $NKE): Q3 EPS $0.54 (est. $0.28), rev $11.3B (est. $11.03B); guides Q4 rev down mid-teens. 🔸 $NIO: Q4 rev $2.7B (est. $2.79B), EV deliveries up 45%; Q1 guide: 41k-43k vehicles, rev $1.69B-$1.76B (est. $2.48B). 🔸 Torrid ( $CURV): Q4 sales -6.1% y/y; guides Q1 sales $264M-$274M (est. $279M), EBITDA below estimates. 🔸 Target ( $TGT): Files $1B note offering due 2035. Energy/Industrials/Materials: 🔸 FedEx ( $FDX): Q3 EPS $4.51 (miss), rev $22.2B (beat); cuts FY25 guidance. 🔸 Nucor ( $NUE): Q1 EPS guide $0.50-$0.60 (est. $1.09); sees lower steel product prices. 🔸 Planet Labs ( $PL): Q4 loss -$0.08 (est. -$0.02), rev $61.6M; Q1 guide below est. 🔸 U.S. Steel ( $X): Q1 EBITDA $125M (in line), EPS loss guided larger than est. 🔸 BP ( $BP): Elliott pushes for cost cuts, possible board changes (Reuters). Healthcare: 🔸 Assembly Bio ( $ASMB): Files $250M mixed shelf. 🔸 Editas ( $EDIT): CFO stepping down. 🔸 Foghorn ( $FHTX): Files $100M shelf. 🔸 J&J ( $JNJ): Plans $55B investment in U.S. manufacturing/research. 🔸 Maravai ( $MRVI): Guides Q1 rev $43M-$45M (est. $63M). 🔸 Vor Bio ( $VOR): Files $350M shelf. Tech/Media/Telecom: 🔸 Micron ( $MU): Q2 EPS $1.56 (beat), rev $8.05B; Q3 guide above est. 🔸 Luminar ( $LAZR): Sees slower Q1, FY25 rev growth 10%-20%. 🔸 Quantum ( $QUBT): Q4 loss -$0.47 (miss), rev $62k; chip foundry launch in 2025. 🔸 Super Micro ( $SMCI): Upgraded to Neutral (JPM), price target raised to $45.

🔸 Upgrades: Accenture ( $ACN): Upgraded to Outperform at Baird, PT $390 American Tower ( $AMT): Upgraded to Overweight at Wells Fargo, PT $230 Blue Owl Capital ( $OBDC): Upgraded to Equal-Weight at Wells Fargo Crown Castle ( $CCI): Upgraded to Equal-Weight at Wells Fargo, PT $105 DouYu ( $DOYU): ADRs upgraded to Hold at HSBC, PT $9 Flowserve ( $FLS): Upgraded to Outperform at Baird, PT $71 Generac ( $GNRC): Upgraded to Neutral at Guggenheim Genesis Energy ( $GEL): Upgraded to Overweight at Wells Fargo, PT $18 Liberty Formula One ( $FWONA): Upgraded to Buy at Seaport Global Securities https://t.co/eMBFE2Jwuf ( $MNDY): Upgraded to Buy at DA Davidson, PT $350 Netflix ( $NFLX): Upgraded to Buy at MoffettNathanson, PT $1,100 Norwegian Cruise ( $NCLH): Upgraded to Overweight at JPMorgan, PT $30 SL Green ( $SLG): Upgraded to Outperform at Evercore ISI, PT $73 Sprouts Farmers ( $SFM): Upgraded to Buy at Deutsche Bank, PT $190 🔸 Downgrades: Campbell's ( $CPB): Downgraded to Equal-Weight at Consumer Edge, PT $40 Cion Investment ( $CION): Downgraded to Underweight at Wells Fargo, PT $10 EastGroup ( $EGP): Downgraded to Inline at Evercore ISI, PT $185 Finward ( $FNWD): Downgraded to Market Perform at Hovde Group FS KKR Capital ( $FSK): Downgraded to Underweight at Wells Fargo, PT $19 Li Auto ( $LI): ADRs downgraded to Neutral at Macquarie, PT $27 RLX Tech ( $RLX): ADRs downgraded to Neutral at Citi, PT $2.50 Sutro Biopharma ( $STRO): Downgraded to Market Perform at Oppenheimer TriplePoint Venture Growth BDC ( $TPVG): Downgraded to Underweight at Wells Fargo

MORNING BID 🔸 Nvidia ( $NVDA): • Q4 adj. EPS $0.89 (est. $0.84) • revs $39.33B (est. $38.05B) • Data center revs $35.6B (+93%) • Auto $570M (+103%) • Gaming $2.5B (-11%) • Q1 revs $43B ±2% (est. $41.78B). 🔸 Amazon ( $AMZN): Debuted Ocelot, its first quantum computing chip. 🔸 Snowflake ( $SNOW): • Q4 EPS $0.30 (est. $0.18) • revs $986.8M (+28%, est. $956.26M) • Q1 product revs guidance $955M-$960M (est. $962.6M); expanded Microsoft partnership. 🔸 Salesforce ( $CRM) • Q4 adj. EPS $2.78 (est. $2.61) • revs $9.99B (missed est. $10.04B) • Q1 guidance below consensus: EPS $2.53-$2.55, revs $9.71B-$9.76B. 🔸 https://t.co/dPTowbRrks ( $AI): • Q3 EPS -$0.12 (est. -$0.25) • revs $98.8M (+26%, est. $98.1M) • Q4 revs guidance $103.6M-$113.6M (est. $108.6M). 🔸 Magnite ( $MGNI) Q4 adj. EPS $0.34 (est. $0.36) revs $194M (est. $184.3M) FY adj. EBITDA guidance mid-teens % (est. +12.8%). 🔸 Nutanix ( $NTNX) Q2 adj. EPS $0.56 (est. $0.47) revs $654.7M (est. $641.86M) Q3 revs guidance $620M-$630M (est. $594.39M). 🔸 eBay ( $EBAY) Q4 adj. EPS $1.25 (est. $1.20) revs $2.6B (est. $2.58B) GMV $19.3B (+4%) Q1 adj. EPS guidance $1.32-$1.36 (est. $1.33) revs $2.52B-$2.56B (est. $2.59B) GMV $18.3B-$18.6B. 🔸 Paramount ( $PARA): Q4 revs $7.98B (est. $8.1B); Paramount+ added 5.6M subs (est. 2.58M). 🔸 Pure Storage ( $PSTG): Q4 EPS $0.45 (est. $0.42), revs $879.8M (est. $869.19M); FY revs guidance $3.515B (est. $3.52B). 🔸 Synopsys ( $SNPS): Q1 EPS $3.03 (est. $2.79), revs $1.46B (est. $1.45B); FY EPS guidance $14.88-$14.96 (est. $14.89). 🔸 TaskUs ( $TASK): Q4 EPS $0.31 (est. $0.34), revs $274.2M (est. $268.8M); FY adj. EBITDA margin ~21%. 🔸 TKO Group ( $TKO): Q4 EPS $0.28 (est. $0.21), revs $642.2M (est. $604M); FY adj. EBITDA $1.35B-$1.39B (FY24: $1.25B). 🔸 Norwegian Cruise Line ( $NCLH): Q4 adj. EPS $0.26 (est. $0.11), revs $2.11B (in line); Q1 Net Yield expected to rise ~0.5% y/y (constant currency). 🔸 Urban Outfitters ( $URBN): Q4 adj. EPS $1.04 (est. $0.94), revs $1.64B (+10%, est. $1.61B); Retail segment sales +6.3%, driven by digital and store growth. 🔸 Agilent ( $A): Q1 adj. EPS $1.31 (est. $1.27), revs $1.68B (est. $1.67B); Q2 guidance below estimates; FY25 revs cut to $6.68B-$6.76B (est. $6.82B). 🔸 CareDx ( $CDNA): Q4 adj. EPS $0.18 (est. $0.15), revs $86.6M (est. $84.56M); FY25 revs guidance $365M-$375M (est. $370.02M); Testing services revs +37% y/y. 🔸 Catalyst Pharma ( $CPRX): Q4 EPS $0.70 (est. $0.55), revs $141.8M (+28%, est. $134.2M); FY revs guidance $545M-$565M (est. $558.1M). 🔸 Outset Medical ( $OM): Filed $100M mixed securities shelf. 🔸 Sarepta ( $SRPT): Q4 adj. EPS $1.90 (in line), revs $658.4M (est. $627.58M). 🔸 Teladoc ( $TDOC): Q4 EPS -$0.28 (est. -$0.24), revs $640.49M (est. $639.55M); FY revs and EBITDA guidance below estimates. 🔸 Tandem Diabetes ( $TNDM): Q4 EPS $0.01 (est. -$0.23), revs $282.6M (est. $251.98M); FY revs guidance $997M-$1.007B (est. $1.008B). 🔸 Universal Health ( $UHS): Q4 adj. EPS $4.92 (est. $4.18), revs $4.11B (est. $4.01B); FY revs and EBITDA guidance above estimates.

#Upgrades - Dec 13, 2024 • $CAH: Wells Fargo Upgrades to Equal Weight from Underweight - PT $127 (from $101) • $CCS: JPMorgan Upgrades to Neutral from Underweight - PT $97 (from $110) • $CIEN: BofA Securities Upgrades to Buy from Neutral - PT $95 (from $70) • $CNC: UBS Upgrades to Buy from Neutral - PT $80 (from $79) • $CRM: KeyBanc Upgrades to Overweight from Sector Weight - PT $440 • $GIS: BofA Securities Upgrades to Buy from Neutral - PT $80 (from $78) • $GLPI: JPMorgan Upgrades to Overweight from Neutral - PT $54 (from $49) • $NCLH: Barclays Upgrades to Overweight from Equalweight - PT $32 (from $28) • $PENN: JPMorgan Upgrades to Overweight from Neutral - PT $27 (from $19) • $PTCT: Morgan Stanley Upgrades to Overweight from Equalweight - PT $67 • $PTEN: Goldman Sachs Upgrades to Buy from Neutral - PT $10 • $PYPL: Wolfe Research Upgrades to Outperform from Peerperform - PT $107 • $RHI: Truist Securities Upgrades to Buy from Hold - PT $90 • $SGMO: Truist Securities Upgrades to Buy from Hold - PT $7 • $SRE: Morgan Stanley Upgrades to Overweight from Equalweight - PT $98 (from $85) • $TASK: Morgan Stanley Upgrades to Overweight from Equalweight - PT $21 (from $18) • $UPBD: Stephens Upgrades to Overweight from Equal Weight - PT $38 • $UPST: Needham Upgrades to Buy from Hold - PT $100 • $VAC: Barclays Upgrades to Overweight from Equalweight - PT $116 (from $97) • $VNOM: KeyBanc Upgrades to Overweight from Sector Weight - PT $62

#Upgrades - Dec 10, 2024 • $AAL: Bernstein Upgrades to Outperform from Market Perform - PT $24 (from $14) • $BALL: Mizuho Upgrades to Outperform from Neutral - PT $67 • $CIFR: JPMorgan Upgrades to Overweight from Neutral - PT $8 • $CLSK: JPMorgan Upgrades to Overweight from Neutral - PT $17 (from $10.50) • $CXW: Wedbush Upgrades to Outperform from Neutral - PT $30 (from $19) • $GM: Morgan Stanley Upgrades to Equalweight from Underweight - PT $54 (from $46) • $GPMT: KBW Upgrades to Market Perform from Underperform - PT $3.25 (from $3) • $IPG: Wells Fargo Upgrades to Equal Weight from Underweight - PT $34 (from $26) • $JLL: KBW Upgrades to Outperform from Market Perform - PT $325 (from $292) • $MARA: JPMorgan Upgrades to Neutral from Underweight - PT $23 (from $12) • $NCLH: Goldman Sachs Upgrades to Buy from Neutral - PT $35 (from $29) • $RSG: Deutsche Bank Upgrades to Buy from Hold - PT $237 (from $219) • $SLG: JPMorgan Upgrades to Neutral from Underweight - PT $80 (from $51) • $TRV: HSBC Upgrades to Buy from Hold - PT $290 • $UPS: BMO Capital Upgrades to Outperform from Market Perform - PT $150 (from $155) • $VMEO: Piper Sandler Upgrades to Overweight from Neutral - PT $10 (from $7) • $VSCO: UBS Upgrades to Neutral from Sell - PT $47 (from $18)